GDD-3898

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameGDD-3898
Drug Alias NameGDD-3898
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl-CoA desaturase inhibitors
TargetsAcyl-CoA desaturase
Therapy Area/IndicationsObesitySebaceous Gland DiseasesAcne Vulgaris +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLipidio Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesLipidio Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsObesitySebaceous Gland DiseasesAcne Vulgaris +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A